D.A. Davidson & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$954K	Sell	1,823 -306	-14%	-$146K	0.01%	947
2025 Q4	$1.24M	Buy	2,129 +58	+3%	+$29.6K	0.01%	810
2025 Q3	$950K	Buy	2,071 +518	+33%	+$193K	0.01%	887
2025 Q2	$470K	Sell	1,553 -620	-29%	-$185K	﹤0.01%	1077
2025 Q1	$720K	Buy	2,173 +1,458	+204%	+$479K	0.01%	893
2024 Q4	$221K	Buy	+715	New	+$201K	﹤0.01%	1304
2024 Q3	–	Sell	-715	Closed	-$200K	–	1415
2024 Q2	$200K	Buy	+715	New	+$170K	﹤0.01%	1285
2023 Q1	–	Sell	-720	Closed	-$209K	–	1389
2022 Q4	$209K	Buy	+720	New	+$70.4K	﹤0.01%	1178
2019 Q1	–	Sell	-1,775	Closed	-$200K	–	1157
2018 Q4	$200K	Sell	1,775 -160	-8%	-$24.8K	﹤0.01%	994
2018 Q3	$414K	Sell	1,935 -5	-0.3%	-$1.25K	0.01%	786
2018 Q2	$543K	Sell	1,940 -995	-34%	-$175K	0.01%	673
2018 Q1	$343K	Sell	2,935 -865	-23%	-$107K	0.01%	823
2017 Q4	$349K	Buy	+3,800	New	+$217K	0.01%	786
2017 Q3	–	Sell	-3,950	Closed	-$64K	–	1618
2017 Q2	$64K	Sell	3,950 -1,200	-23%	-$18.8K	﹤0.01%	1440
2017 Q1	$79K	Buy	5,150 +4,650	+930%	+$73.1K	﹤0.01%	1340
2016 Q4	$7K	Buy	+500	New	+$8.03K	﹤0.01%	2185